Diagnosis of Dengue in the Post-Acute Phase

Diagnostic Approach

The Centers for Disease Control and Prevention recommends that dengue cannot be excluded clinically in the post-acute phase; serological confirmation using IgM antibody tests is required to rule out infection 1, 2.
The American College of Physicians suggests that serological tests are mandatory after 7 days of symptom onset, and a negative result for IgM antibodies for both dengue and Zika rules out recent infection with either virus 1, 2.
The World Health Organization notes that the clinical presentation of dengue is non-specific, with symptoms overlapping with multiple pathologies, including chikungunya, malaria, and leptospirosis 1, 3.

The Centers for Disease Control and Prevention recommends performing nucleic acid amplification tests (NAAT/PCR) on serum during the first week of illness when viremia is present 2, 3.
If NAAT is negative, IgM serology should be performed; a combined negative result of NAAT and IgM suggests that the patient did not have a recent flavivirus infection 1, 2.
In the post-acute phase, IgM serology is the diagnostic test of choice, with antibodies typically developing during the first week of illness and remaining detectable for 2-3 months 2, 3.

The Centers for Disease Control and Prevention notes that IgG antibodies can persist for months or years after dengue infection, and a positive result only does not confirm acute infection 4.
There is cross-reactivity with other flaviviruses, such as yellow fever and Japanese encephalitis, which complicates serological diagnosis 3.
Pregnant women require thorough evaluation, including both NAAT and serology for dengue and Zika, due to the risk of maternal death, hemorrhage, and vertical transmission 1, 2, 3.

The American College of Physicians advises against relying solely on clinical presentation to exclude dengue, as the critical phase with warning signs typically appears around days 3-7 of illness 5.
The Centers for Disease Control and Prevention warns against interpreting a negative IgM result in the early phase (<7 days) as definitive exclusion, as this may reflect sampling before antibody development 1, 2, 3.